GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,177,000 | -0.0% | 50,000 | 0.0% | 0.27% | +18.3% |
| Q1 2022 | $2,178,000 | -1.2% | 50,000 | 0.0% | 0.23% | -3.0% |
| Q4 2021 | $2,205,000 | +15.4% | 50,000 | 0.0% | 0.24% | 0.0% |
| Q3 2021 | $1,911,000 | -4.0% | 50,000 | 0.0% | 0.24% | -9.2% |
| Q2 2021 | $1,991,000 | +11.5% | 50,000 | 0.0% | 0.26% | +6.1% |
| Q1 2021 | $1,785,000 | -3.0% | 50,000 | 0.0% | 0.25% | -17.7% |
| Q4 2020 | $1,840,000 | -2.2% | 50,000 | 0.0% | 0.30% | -22.7% |
| Q3 2020 | $1,882,000 | -7.7% | 50,000 | 0.0% | 0.39% | -16.1% |
| Q2 2020 | $2,040,000 | +53.8% | 50,000 | +42.9% | 0.46% | +62.3% |
| Q1 2020 | $1,326,000 | -19.4% | 35,000 | 0.0% | 0.28% | +15.0% |
| Q4 2019 | $1,645,000 | +10.1% | 35,000 | 0.0% | 0.25% | +3.3% |
| Q3 2019 | $1,494,000 | +6.6% | 35,000 | 0.0% | 0.24% | +6.7% |
| Q2 2019 | $1,401,000 | -4.4% | 35,000 | 0.0% | 0.22% | -5.9% |
| Q1 2019 | $1,465,000 | +9.6% | 35,000 | 0.0% | 0.24% | -1.2% |
| Q4 2018 | $1,337,000 | -5.7% | 35,000 | 0.0% | 0.24% | +3.4% |
| Q3 2018 | $1,418,000 | +2.4% | 35,000 | 0.0% | 0.23% | -3.7% |
| Q2 2018 | $1,385,000 | +1.3% | 35,000 | 0.0% | 0.24% | -6.9% |
| Q1 2018 | $1,367,000 | +28.5% | 35,000 | +16.7% | 0.26% | +27.5% |
| Q4 2017 | $1,064,000 | -12.6% | 30,000 | 0.0% | 0.20% | -16.0% |
| Q3 2017 | $1,218,000 | -5.9% | 30,000 | 0.0% | 0.24% | -9.3% |
| Q2 2017 | $1,294,000 | +2.3% | 30,000 | 0.0% | 0.27% | +3.9% |
| Q1 2017 | $1,265,000 | +9.5% | 30,000 | 0.0% | 0.26% | +5.7% |
| Q4 2016 | $1,155,000 | +33.8% | 30,000 | +50.0% | 0.24% | +23.2% |
| Q3 2016 | $863,000 | -0.5% | 20,000 | 0.0% | 0.20% | -6.2% |
| Q2 2016 | $867,000 | +113.5% | 20,000 | +100.0% | 0.21% | +91.8% |
| Q1 2016 | $406,000 | +0.5% | 10,000 | 0.0% | 0.11% | -1.8% |
| Q4 2015 | $404,000 | +4.9% | 10,000 | 0.0% | 0.11% | -3.4% |
| Q3 2015 | $385,000 | -7.7% | 10,000 | 0.0% | 0.12% | -7.2% |
| Q2 2015 | $417,000 | – | 10,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |